Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Gupta

Showing results (281-290 of 353) with videos related to

Pageof 36
Sort By:
Journal of Blood Medicine|September 2, 2017
New developments in the management of relapsed/refractory multiple myeloma - the role of ixazomibPaul G Richardson, Shaji Kumar, Jacob P Laubach, et al.
Future Oncology (London, England)|April 3, 2015
The investigational proteasome inhibitor ixazomib for the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Journal of Evidence-Based Complementary & Alternative Medicine|July 24, 2014
Hering's Law Assessment Tool revisited: introducing a modified novel version--Patients' Response Assessment Tool after Homeopathic Treatment (PRATHoT) in chronic casesSubhranil Saha, Munmun Koley, Jogendra Singh Arya, et al.
Clinical Science (London, England : 1979)|December 26, 2001
Threshold for adrenomedullary activation and increased cardiac work during mild core hypothermiaSteven M Frank, Christine G Cattaneo, Mary Beth Wieneke-Brady, et al.
Journal of Clinical Pharmacology|August 8, 2017
A Phase 1 Study to Assess the Relative Bioavailability of Two Capsule Formulations of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or LymphomaMichael J Hanley, Neeraj Gupta, Karthik Venkatakrishnan, et al.
BMJ Open Quality|April 8, 2024
Implementing the practice of early skin-to-skin contact among infants ≥35 weeks gestation born vaginally: a quality improvement studyNaveen Kumar Bhardwaj, Rohit Sasidharan, Nisha Toteja, et al.
Clinical Pharmacology in Drug Development|January 16, 2025
A Drug-Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non-Small Cell Lung CancerMichael J Hanley, Steven Zhang, Nick Pavlakis, et al.
NPJ Digital Medicine|July 29, 2024
Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myelomaZeshan Hussain, Edward De Brouwer, Rebecca Boiarsky, et al.
Targeted Oncology|November 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
The British Journal of Nutrition|September 16, 2024
Comparative efficacies of vitamin D supplementation regimens in infants: a systematic review and network meta-analysisThangaraj Abiramalatha, Viraraghavan Vadakkencherry Ramaswamy, Sivam Thanigainathan, et al.
Pageof 36

Showing results (281-290 of 353) with videos related to

Sort By:
Pageof 36
Journal of Blood Medicine|September 2, 2017
New developments in the management of relapsed/refractory multiple myeloma - the role of ixazomibPaul G Richardson, Shaji Kumar, Jacob P Laubach, et al.
Future Oncology (London, England)|April 3, 2015
The investigational proteasome inhibitor ixazomib for the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Journal of Evidence-Based Complementary & Alternative Medicine|July 24, 2014
Hering's Law Assessment Tool revisited: introducing a modified novel version--Patients' Response Assessment Tool after Homeopathic Treatment (PRATHoT) in chronic casesSubhranil Saha, Munmun Koley, Jogendra Singh Arya, et al.
Clinical Science (London, England : 1979)|December 26, 2001
Threshold for adrenomedullary activation and increased cardiac work during mild core hypothermiaSteven M Frank, Christine G Cattaneo, Mary Beth Wieneke-Brady, et al.
Journal of Clinical Pharmacology|August 8, 2017
A Phase 1 Study to Assess the Relative Bioavailability of Two Capsule Formulations of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or LymphomaMichael J Hanley, Neeraj Gupta, Karthik Venkatakrishnan, et al.
BMJ Open Quality|April 8, 2024
Implementing the practice of early skin-to-skin contact among infants ≥35 weeks gestation born vaginally: a quality improvement studyNaveen Kumar Bhardwaj, Rohit Sasidharan, Nisha Toteja, et al.
Clinical Pharmacology in Drug Development|January 16, 2025
A Drug-Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non-Small Cell Lung CancerMichael J Hanley, Steven Zhang, Nick Pavlakis, et al.
NPJ Digital Medicine|July 29, 2024
Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myelomaZeshan Hussain, Edward De Brouwer, Rebecca Boiarsky, et al.
Targeted Oncology|November 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
The British Journal of Nutrition|September 16, 2024
Comparative efficacies of vitamin D supplementation regimens in infants: a systematic review and network meta-analysisThangaraj Abiramalatha, Viraraghavan Vadakkencherry Ramaswamy, Sivam Thanigainathan, et al.
Pageof 36